Working... Menu

Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00800969
Recruitment Status : Withdrawn
First Posted : December 3, 2008
Last Update Posted : June 23, 2016
Information provided by (Responsible Party):
University of Zurich

Brief Summary:

This prospective study includes patients with histologically proven cancer of the esophagogastric junction (Siewert Type II and III) and the stomach. Aim of the study is to evaluate the accuracy of PET-CT for the preoperative assessment of lymph node metastasis. The evaluation includes a combination with standard diagnostic tools (endoluminal ultrasound, CT and diagnostic laparoscopy prior to neoadjuvant therapy). Standardized D2-lymphadenectomy is performed and individual lymph node stations (Nr 1-12 according to the Japanese classification) are histopathologically examined. Furthermore we evaluate the role of the PET-CT for early metabolic response evaluation in patients receiving neoadjuvant chemotherapy.

  • Trial with surgical intervention

Condition or disease Intervention/treatment Phase
Adenocarcinoma Stomach Cancer Cancer of Esophagogastric Junction Procedure: FDG-PET-CT Phase 2

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Single (Investigator)
Primary Purpose: Diagnostic
Study Start Date : October 2008
Estimated Primary Completion Date : January 2015

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
all patients
all patients with Adenocarcinoma
Procedure: FDG-PET-CT
Radiologic standard procedure

Primary Outcome Measures :
  1. Diagnostic Accuracy of PET-CT [ Time Frame: preoperative ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion criteria:

  • Histological prove of adenocarcinoma of the stomach.

Exclusion criteria:

  • Recurrent gastric carcinoma
  • No informed consent
  • Previous malignancy (exception: thyroid, bladder in situ, Cervix in situ)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00800969

Layout table for location information
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Layout table for investigator information
Principal Investigator: Kuno Lehmann, MD University Hospital Zurich, Visceral surgery

Layout table for additonal information
Responsible Party: University of Zurich Identifier: NCT00800969     History of Changes
Other Study ID Numbers: VIS-UGI-1
First Posted: December 3, 2008    Key Record Dates
Last Update Posted: June 23, 2016
Last Verified: June 2016

Keywords provided by University of Zurich:
Adenocarcinoma of the stomach and esophagogastric junction

Additional relevant MeSH terms:
Layout table for MeSH terms
Stomach Neoplasms
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Stomach Diseases